nodes	percent_of_prediction	percent_of_DWPC	metapath
Lenalidomide—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0778	0.167	CbGbCtD
Lenalidomide—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0704	0.151	CbGbCtD
Lenalidomide—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0607	0.131	CbGbCtD
Lenalidomide—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.059	0.127	CbGbCtD
Lenalidomide—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0533	0.115	CbGbCtD
Lenalidomide—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0533	0.115	CbGbCtD
Lenalidomide—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0511	0.11	CbGbCtD
Lenalidomide—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0396	0.085	CbGbCtD
Lenalidomide—CDH5—endothelium—acquired immunodeficiency syndrome	0.0126	0.105	CbGeAlD
Lenalidomide—TNFSF11—lymphoid tissue—acquired immunodeficiency syndrome	0.00579	0.0485	CbGeAlD
Lenalidomide—TNFSF11—blood—acquired immunodeficiency syndrome	0.00545	0.0456	CbGeAlD
Lenalidomide—TNFSF11—bone marrow—acquired immunodeficiency syndrome	0.00527	0.0441	CbGeAlD
Lenalidomide—TNFSF11—lung—acquired immunodeficiency syndrome	0.00478	0.04	CbGeAlD
Lenalidomide—Pomalidomide—TNF—acquired immunodeficiency syndrome	0.00453	0.608	CrCbGaD
Lenalidomide—CDH5—lymphoid tissue—acquired immunodeficiency syndrome	0.00435	0.0365	CbGeAlD
Lenalidomide—CDH5—blood—acquired immunodeficiency syndrome	0.0041	0.0343	CbGeAlD
Lenalidomide—CDH5—bone marrow—acquired immunodeficiency syndrome	0.00397	0.0332	CbGeAlD
Lenalidomide—CDH5—spinal cord—acquired immunodeficiency syndrome	0.00395	0.0331	CbGeAlD
Lenalidomide—CRBN—retina—acquired immunodeficiency syndrome	0.00389	0.0326	CbGeAlD
Lenalidomide—CDH5—vagina—acquired immunodeficiency syndrome	0.0038	0.0318	CbGeAlD
Lenalidomide—CDH5—lung—acquired immunodeficiency syndrome	0.00359	0.0301	CbGeAlD
Lenalidomide—CDH5—nervous system—acquired immunodeficiency syndrome	0.00333	0.0279	CbGeAlD
Lenalidomide—TNFSF11—lymph node—acquired immunodeficiency syndrome	0.00327	0.0273	CbGeAlD
Lenalidomide—CDH5—central nervous system—acquired immunodeficiency syndrome	0.0032	0.0268	CbGeAlD
Lenalidomide—Thalidomide—TNF—acquired immunodeficiency syndrome	0.00292	0.392	CrCbGaD
Lenalidomide—CRBN—lymphoid tissue—acquired immunodeficiency syndrome	0.00277	0.0232	CbGeAlD
Lenalidomide—CRBN—digestive system—acquired immunodeficiency syndrome	0.00273	0.0229	CbGeAlD
Lenalidomide—CRBN—blood—acquired immunodeficiency syndrome	0.0026	0.0218	CbGeAlD
Lenalidomide—CDH5—brain—acquired immunodeficiency syndrome	0.00254	0.0213	CbGeAlD
Lenalidomide—CRBN—bone marrow—acquired immunodeficiency syndrome	0.00252	0.0211	CbGeAlD
Lenalidomide—CRBN—spinal cord—acquired immunodeficiency syndrome	0.00251	0.021	CbGeAlD
Lenalidomide—CDH5—lymph node—acquired immunodeficiency syndrome	0.00246	0.0206	CbGeAlD
Lenalidomide—CRBN—vagina—acquired immunodeficiency syndrome	0.00241	0.0202	CbGeAlD
Lenalidomide—CRBN—lung—acquired immunodeficiency syndrome	0.00228	0.0191	CbGeAlD
Lenalidomide—PTGS2—endothelium—acquired immunodeficiency syndrome	0.00218	0.0182	CbGeAlD
Lenalidomide—CRBN—nervous system—acquired immunodeficiency syndrome	0.00211	0.0177	CbGeAlD
Lenalidomide—CRBN—central nervous system—acquired immunodeficiency syndrome	0.00203	0.017	CbGeAlD
Lenalidomide—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.00193	0.0162	CbGeAlD
Lenalidomide—CRBN—brain—acquired immunodeficiency syndrome	0.00162	0.0135	CbGeAlD
Lenalidomide—CRBN—lymph node—acquired immunodeficiency syndrome	0.00156	0.0131	CbGeAlD
Lenalidomide—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.0012	0.01	CbGeAlD
Lenalidomide—PTGS2—skin of body—acquired immunodeficiency syndrome	0.00093	0.00779	CbGeAlD
Lenalidomide—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.000753	0.00631	CbGeAlD
Lenalidomide—PTGS2—digestive system—acquired immunodeficiency syndrome	0.000744	0.00623	CbGeAlD
Lenalidomide—PTGS2—blood—acquired immunodeficiency syndrome	0.000709	0.00593	CbGeAlD
Lenalidomide—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.000686	0.00574	CbGeAlD
Lenalidomide—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.000683	0.00572	CbGeAlD
Lenalidomide—PTGS2—vagina—acquired immunodeficiency syndrome	0.000657	0.0055	CbGeAlD
Lenalidomide—ABCB1—retina—acquired immunodeficiency syndrome	0.000655	0.00549	CbGeAlD
Lenalidomide—PTGS2—lung—acquired immunodeficiency syndrome	0.000621	0.0052	CbGeAlD
Lenalidomide—PTGS2—nervous system—acquired immunodeficiency syndrome	0.000575	0.00482	CbGeAlD
Lenalidomide—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.000554	0.00464	CbGeAlD
Lenalidomide—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000466	0.0039	CbGeAlD
Lenalidomide—ABCB1—digestive system—acquired immunodeficiency syndrome	0.00046	0.00385	CbGeAlD
Lenalidomide—PTGS2—brain—acquired immunodeficiency syndrome	0.00044	0.00368	CbGeAlD
Lenalidomide—ABCB1—blood—acquired immunodeficiency syndrome	0.000438	0.00367	CbGeAlD
Lenalidomide—PTGS2—lymph node—acquired immunodeficiency syndrome	0.000425	0.00356	CbGeAlD
Lenalidomide—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000424	0.00355	CbGeAlD
Lenalidomide—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000422	0.00354	CbGeAlD
Lenalidomide—ABCB1—vagina—acquired immunodeficiency syndrome	0.000406	0.0034	CbGeAlD
Lenalidomide—ABCB1—lung—acquired immunodeficiency syndrome	0.000384	0.00322	CbGeAlD
Lenalidomide—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000356	0.00298	CbGeAlD
Lenalidomide—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000343	0.00287	CbGeAlD
Lenalidomide—ABCB1—brain—acquired immunodeficiency syndrome	0.000272	0.00228	CbGeAlD
Lenalidomide—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000263	0.0022	CbGeAlD
Lenalidomide—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.00029	CcSEcCtD
Lenalidomide—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000289	CcSEcCtD
Lenalidomide—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000289	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000288	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000117	0.000288	CcSEcCtD
Lenalidomide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000117	0.000287	CcSEcCtD
Lenalidomide—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000117	0.000287	CcSEcCtD
Lenalidomide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000287	CcSEcCtD
Lenalidomide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000287	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.000287	CcSEcCtD
Lenalidomide—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000287	CcSEcCtD
Lenalidomide—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000286	CcSEcCtD
Lenalidomide—Pain—Indinavir—acquired immunodeficiency syndrome	0.000116	0.000285	CcSEcCtD
Lenalidomide—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000116	0.000285	CcSEcCtD
Lenalidomide—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000116	0.000285	CcSEcCtD
Lenalidomide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000116	0.000285	CcSEcCtD
Lenalidomide—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000284	CcSEcCtD
Lenalidomide—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000284	CcSEcCtD
Lenalidomide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000115	0.000283	CcSEcCtD
Lenalidomide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000115	0.000283	CcSEcCtD
Lenalidomide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000115	0.000283	CcSEcCtD
Lenalidomide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.000283	CcSEcCtD
Lenalidomide—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000283	CcSEcCtD
Lenalidomide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000115	0.000282	CcSEcCtD
Lenalidomide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000115	0.000282	CcSEcCtD
Lenalidomide—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000281	CcSEcCtD
Lenalidomide—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.000281	CcSEcCtD
Lenalidomide—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000281	CcSEcCtD
Lenalidomide—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000281	CcSEcCtD
Lenalidomide—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000281	CcSEcCtD
Lenalidomide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.00028	CcSEcCtD
Lenalidomide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.00028	CcSEcCtD
Lenalidomide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.00028	CcSEcCtD
Lenalidomide—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.00028	CcSEcCtD
Lenalidomide—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.00028	CcSEcCtD
Lenalidomide—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000279	CcSEcCtD
Lenalidomide—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000278	CcSEcCtD
Lenalidomide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000113	0.000278	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000278	CcSEcCtD
Lenalidomide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000277	CcSEcCtD
Lenalidomide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000276	CcSEcCtD
Lenalidomide—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000275	CcSEcCtD
Lenalidomide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000112	0.000275	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000274	CcSEcCtD
Lenalidomide—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000274	CcSEcCtD
Lenalidomide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000274	CcSEcCtD
Lenalidomide—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000273	CcSEcCtD
Lenalidomide—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000273	CcSEcCtD
Lenalidomide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000111	0.000273	CcSEcCtD
Lenalidomide—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000273	CcSEcCtD
Lenalidomide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000273	CcSEcCtD
Lenalidomide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000111	0.000273	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000272	CcSEcCtD
Lenalidomide—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.000272	CcSEcCtD
Lenalidomide—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000272	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.000272	CcSEcCtD
Lenalidomide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000111	0.000271	CcSEcCtD
Lenalidomide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.000271	CcSEcCtD
Lenalidomide—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.00027	CcSEcCtD
Lenalidomide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.00027	CcSEcCtD
Lenalidomide—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.00027	CcSEcCtD
Lenalidomide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000269	CcSEcCtD
Lenalidomide—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00011	0.000269	CcSEcCtD
Lenalidomide—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00011	0.000269	CcSEcCtD
Lenalidomide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00011	0.000269	CcSEcCtD
Lenalidomide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00011	0.000269	CcSEcCtD
Lenalidomide—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.000268	CcSEcCtD
Lenalidomide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000109	0.000268	CcSEcCtD
Lenalidomide—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000268	CcSEcCtD
Lenalidomide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000268	CcSEcCtD
Lenalidomide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000109	0.000267	CcSEcCtD
Lenalidomide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000267	CcSEcCtD
Lenalidomide—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000267	CcSEcCtD
Lenalidomide—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000267	CcSEcCtD
Lenalidomide—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000266	CcSEcCtD
Lenalidomide—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000266	CcSEcCtD
Lenalidomide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000265	CcSEcCtD
Lenalidomide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000265	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000265	CcSEcCtD
Lenalidomide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000108	0.000265	CcSEcCtD
Lenalidomide—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000264	CcSEcCtD
Lenalidomide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000264	CcSEcCtD
Lenalidomide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000107	0.000263	CcSEcCtD
Lenalidomide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000107	0.000263	CcSEcCtD
Lenalidomide—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000263	CcSEcCtD
Lenalidomide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000107	0.000263	CcSEcCtD
Lenalidomide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000262	CcSEcCtD
Lenalidomide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000107	0.000262	CcSEcCtD
Lenalidomide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000262	CcSEcCtD
Lenalidomide—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000261	CcSEcCtD
Lenalidomide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000106	0.000261	CcSEcCtD
Lenalidomide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000106	0.00026	CcSEcCtD
Lenalidomide—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.00026	CcSEcCtD
Lenalidomide—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.00026	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.00026	CcSEcCtD
Lenalidomide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000106	0.00026	CcSEcCtD
Lenalidomide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.00026	CcSEcCtD
Lenalidomide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000106	0.00026	CcSEcCtD
Lenalidomide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.000259	CcSEcCtD
Lenalidomide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000259	CcSEcCtD
Lenalidomide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000106	0.000259	CcSEcCtD
Lenalidomide—Headache—Stavudine—acquired immunodeficiency syndrome	0.000105	0.000258	CcSEcCtD
Lenalidomide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000105	0.000258	CcSEcCtD
Lenalidomide—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000258	CcSEcCtD
Lenalidomide—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000258	CcSEcCtD
Lenalidomide—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000258	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000257	CcSEcCtD
Lenalidomide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000105	0.000257	CcSEcCtD
Lenalidomide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000104	0.000256	CcSEcCtD
Lenalidomide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000104	0.000256	CcSEcCtD
Lenalidomide—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000256	CcSEcCtD
Lenalidomide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000255	CcSEcCtD
Lenalidomide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000104	0.000254	CcSEcCtD
Lenalidomide—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000254	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000254	CcSEcCtD
Lenalidomide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000103	0.000254	CcSEcCtD
Lenalidomide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000103	0.000253	CcSEcCtD
Lenalidomide—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000252	CcSEcCtD
Lenalidomide—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000252	CcSEcCtD
Lenalidomide—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000251	CcSEcCtD
Lenalidomide—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.00025	CcSEcCtD
Lenalidomide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.00025	CcSEcCtD
Lenalidomide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.00025	CcSEcCtD
Lenalidomide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.00025	CcSEcCtD
Lenalidomide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.000249	CcSEcCtD
Lenalidomide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.000249	CcSEcCtD
Lenalidomide—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000248	CcSEcCtD
Lenalidomide—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000248	CcSEcCtD
Lenalidomide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000248	CcSEcCtD
Lenalidomide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000248	CcSEcCtD
Lenalidomide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000247	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.000246	CcSEcCtD
Lenalidomide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.0001	0.000246	CcSEcCtD
Lenalidomide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.0001	0.000245	CcSEcCtD
Lenalidomide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000245	CcSEcCtD
Lenalidomide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.0001	0.000245	CcSEcCtD
Lenalidomide—Nausea—Stavudine—acquired immunodeficiency syndrome	9.98e-05	0.000245	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	9.96e-05	0.000244	CcSEcCtD
Lenalidomide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	9.94e-05	0.000244	CcSEcCtD
Lenalidomide—Insomnia—Saquinavir—acquired immunodeficiency syndrome	9.89e-05	0.000242	CcSEcCtD
Lenalidomide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	9.87e-05	0.000242	CcSEcCtD
Lenalidomide—Nausea—Abacavir—acquired immunodeficiency syndrome	9.84e-05	0.000241	CcSEcCtD
Lenalidomide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	9.82e-05	0.000241	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	9.81e-05	0.00024	CcSEcCtD
Lenalidomide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	9.79e-05	0.00024	CcSEcCtD
Lenalidomide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	9.76e-05	0.000239	CcSEcCtD
Lenalidomide—Asthenia—Indinavir—acquired immunodeficiency syndrome	9.75e-05	0.000239	CcSEcCtD
Lenalidomide—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	9.75e-05	0.000239	CcSEcCtD
Lenalidomide—Hypotension—Lamivudine—acquired immunodeficiency syndrome	9.75e-05	0.000239	CcSEcCtD
Lenalidomide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	9.72e-05	0.000238	CcSEcCtD
Lenalidomide—Constipation—Ritonavir—acquired immunodeficiency syndrome	9.71e-05	0.000238	CcSEcCtD
Lenalidomide—Pain—Ritonavir—acquired immunodeficiency syndrome	9.71e-05	0.000238	CcSEcCtD
Lenalidomide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	9.71e-05	0.000238	CcSEcCtD
Lenalidomide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	9.71e-05	0.000238	CcSEcCtD
Lenalidomide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	9.66e-05	0.000237	CcSEcCtD
Lenalidomide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	9.62e-05	0.000236	CcSEcCtD
Lenalidomide—Pruritus—Indinavir—acquired immunodeficiency syndrome	9.61e-05	0.000236	CcSEcCtD
Lenalidomide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	9.5e-05	0.000233	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	9.5e-05	0.000233	CcSEcCtD
Lenalidomide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	9.46e-05	0.000232	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	9.44e-05	0.000231	CcSEcCtD
Lenalidomide—Insomnia—Lamivudine—acquired immunodeficiency syndrome	9.43e-05	0.000231	CcSEcCtD
Lenalidomide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	9.43e-05	0.000231	CcSEcCtD
Lenalidomide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	9.36e-05	0.00023	CcSEcCtD
Lenalidomide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	9.36e-05	0.000229	CcSEcCtD
Lenalidomide—Pain—Saquinavir—acquired immunodeficiency syndrome	9.35e-05	0.000229	CcSEcCtD
Lenalidomide—Constipation—Saquinavir—acquired immunodeficiency syndrome	9.35e-05	0.000229	CcSEcCtD
Lenalidomide—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	9.3e-05	0.000228	CcSEcCtD
Lenalidomide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	9.3e-05	0.000228	CcSEcCtD
Lenalidomide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	9.29e-05	0.000228	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	9.29e-05	0.000228	CcSEcCtD
Lenalidomide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	9.27e-05	0.000227	CcSEcCtD
Lenalidomide—Rash—Zidovudine—acquired immunodeficiency syndrome	9.21e-05	0.000226	CcSEcCtD
Lenalidomide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	9.21e-05	0.000226	CcSEcCtD
Lenalidomide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	9.2e-05	0.000226	CcSEcCtD
Lenalidomide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	9.18e-05	0.000225	CcSEcCtD
Lenalidomide—Headache—Zidovudine—acquired immunodeficiency syndrome	9.15e-05	0.000224	CcSEcCtD
Lenalidomide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	9.08e-05	0.000223	CcSEcCtD
Lenalidomide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	9.07e-05	0.000222	CcSEcCtD
Lenalidomide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	9.05e-05	0.000222	CcSEcCtD
Lenalidomide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	9.02e-05	0.000221	CcSEcCtD
Lenalidomide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	9.01e-05	0.000221	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	9e-05	0.000221	CcSEcCtD
Lenalidomide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	8.99e-05	0.00022	CcSEcCtD
Lenalidomide—Dizziness—Indinavir—acquired immunodeficiency syndrome	8.98e-05	0.00022	CcSEcCtD
Lenalidomide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	8.98e-05	0.00022	CcSEcCtD
Lenalidomide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	8.98e-05	0.00022	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	8.94e-05	0.000219	CcSEcCtD
Lenalidomide—Pain—Lamivudine—acquired immunodeficiency syndrome	8.92e-05	0.000219	CcSEcCtD
Lenalidomide—Constipation—Lamivudine—acquired immunodeficiency syndrome	8.92e-05	0.000219	CcSEcCtD
Lenalidomide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	8.81e-05	0.000216	CcSEcCtD
Lenalidomide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	8.78e-05	0.000215	CcSEcCtD
Lenalidomide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	8.69e-05	0.000213	CcSEcCtD
Lenalidomide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	8.68e-05	0.000213	CcSEcCtD
Lenalidomide—Nausea—Zidovudine—acquired immunodeficiency syndrome	8.68e-05	0.000213	CcSEcCtD
Lenalidomide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	8.64e-05	0.000212	CcSEcCtD
Lenalidomide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	8.64e-05	0.000212	CcSEcCtD
Lenalidomide—Vomiting—Indinavir—acquired immunodeficiency syndrome	8.64e-05	0.000212	CcSEcCtD
Lenalidomide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	8.59e-05	0.000211	CcSEcCtD
Lenalidomide—Rash—Indinavir—acquired immunodeficiency syndrome	8.57e-05	0.00021	CcSEcCtD
Lenalidomide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	8.56e-05	0.00021	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	8.53e-05	0.000209	CcSEcCtD
Lenalidomide—Headache—Indinavir—acquired immunodeficiency syndrome	8.51e-05	0.000209	CcSEcCtD
Lenalidomide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	8.49e-05	0.000208	CcSEcCtD
Lenalidomide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	8.4e-05	0.000206	CcSEcCtD
Lenalidomide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	8.37e-05	0.000205	CcSEcCtD
Lenalidomide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	8.28e-05	0.000203	CcSEcCtD
Lenalidomide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	8.24e-05	0.000202	CcSEcCtD
Lenalidomide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	8.24e-05	0.000202	CcSEcCtD
Lenalidomide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	8.16e-05	0.0002	CcSEcCtD
Lenalidomide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	8.15e-05	0.0002	CcSEcCtD
Lenalidomide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	8.12e-05	0.000199	CcSEcCtD
Lenalidomide—Rash—Efavirenz—acquired immunodeficiency syndrome	8.09e-05	0.000198	CcSEcCtD
Lenalidomide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	8.09e-05	0.000198	CcSEcCtD
Lenalidomide—Nausea—Indinavir—acquired immunodeficiency syndrome	8.07e-05	0.000198	CcSEcCtD
Lenalidomide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	8.05e-05	0.000197	CcSEcCtD
Lenalidomide—Headache—Efavirenz—acquired immunodeficiency syndrome	8.04e-05	0.000197	CcSEcCtD
Lenalidomide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	8.04e-05	0.000197	CcSEcCtD
Lenalidomide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	7.84e-05	0.000192	CcSEcCtD
Lenalidomide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	7.81e-05	0.000191	CcSEcCtD
Lenalidomide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	7.77e-05	0.000191	CcSEcCtD
Lenalidomide—Rash—Delavirdine—acquired immunodeficiency syndrome	7.74e-05	0.00019	CcSEcCtD
Lenalidomide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	7.74e-05	0.00019	CcSEcCtD
Lenalidomide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	7.73e-05	0.00019	CcSEcCtD
Lenalidomide—Headache—Delavirdine—acquired immunodeficiency syndrome	7.69e-05	0.000189	CcSEcCtD
Lenalidomide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	7.68e-05	0.000188	CcSEcCtD
Lenalidomide—Nausea—Efavirenz—acquired immunodeficiency syndrome	7.62e-05	0.000187	CcSEcCtD
Lenalidomide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	7.51e-05	0.000184	CcSEcCtD
Lenalidomide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	7.48e-05	0.000183	CcSEcCtD
Lenalidomide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	7.48e-05	0.000183	CcSEcCtD
Lenalidomide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	7.38e-05	0.000181	CcSEcCtD
Lenalidomide—Nausea—Delavirdine—acquired immunodeficiency syndrome	7.3e-05	0.000179	CcSEcCtD
Lenalidomide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	7.23e-05	0.000177	CcSEcCtD
Lenalidomide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	7.22e-05	0.000177	CcSEcCtD
Lenalidomide—Rash—Ritonavir—acquired immunodeficiency syndrome	7.16e-05	0.000176	CcSEcCtD
Lenalidomide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	7.15e-05	0.000175	CcSEcCtD
Lenalidomide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	7.14e-05	0.000175	CcSEcCtD
Lenalidomide—Headache—Ritonavir—acquired immunodeficiency syndrome	7.12e-05	0.000174	CcSEcCtD
Lenalidomide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	6.95e-05	0.00017	CcSEcCtD
Lenalidomide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	6.9e-05	0.000169	CcSEcCtD
Lenalidomide—Rash—Saquinavir—acquired immunodeficiency syndrome	6.89e-05	0.000169	CcSEcCtD
Lenalidomide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	6.89e-05	0.000169	CcSEcCtD
Lenalidomide—Headache—Saquinavir—acquired immunodeficiency syndrome	6.85e-05	0.000168	CcSEcCtD
Lenalidomide—Nausea—Ritonavir—acquired immunodeficiency syndrome	6.75e-05	0.000165	CcSEcCtD
Lenalidomide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	6.63e-05	0.000163	CcSEcCtD
Lenalidomide—Rash—Lamivudine—acquired immunodeficiency syndrome	6.58e-05	0.000161	CcSEcCtD
Lenalidomide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	6.57e-05	0.000161	CcSEcCtD
Lenalidomide—Headache—Lamivudine—acquired immunodeficiency syndrome	6.53e-05	0.00016	CcSEcCtD
Lenalidomide—Nausea—Saquinavir—acquired immunodeficiency syndrome	6.49e-05	0.000159	CcSEcCtD
Lenalidomide—Nausea—Lamivudine—acquired immunodeficiency syndrome	6.19e-05	0.000152	CcSEcCtD
